Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis

Table 1

Insulin-like growth factor (IGF)-I or Leishmania antigen detection in lesions of cutaneous leishmaniases patients according to the duration of illness.

	% of positive cases	Duration of illness	% detection ()
Leishmanial antigens	84.3% ()	Early	92.8% (13/14)
		Intermediate	89.4% (17/19)
		Late	72.2% (13/18)
IGF-I	70.5% ()	Early	64.2% (9/14)
		Intermediate	68.4% (13/19)
		Late	77.7% (14/18)

Duration of illness: early = lesions with less than 30 days; intermediate = lesions with 30-60 days; late = lesions with more than 90 days.